Disease-Specific Complications of Chronic Lymphocytic Leukemia
Open Access
- 1 January 2008
- journal article
- Published by American Society of Hematology in Hematology
- Vol. 2008 (1), 450-456
- https://doi.org/10.1182/asheducation-2008.1.450
Abstract
The majority of disease-specific complications in chronic lymphocytic leukemia (CLL), notably infection and autoimmunity, relate to the underlying alterations in immune function. Both cellular and humoral immunity are impaired with qualitative and quantitative defects in B cells, T cells, NK cells, neutrophils and the monocyte/macrophage lineage. Virtually all patients have reduced immunoglobulin levels, even in early stages, and this is associated with an increased frequency and severity of infection. Although prophylactic intravenous immunoglobulin may be of clinical benefit in selected patients, it does not reduce mortality and is certainly not cost-effective. Autoimmune complications occur in up to a quarter of CLL patients and predominantly target blood cells. Autoimmune hemolytic anemia (AHA) is the most common manifestation; immune thrombocytopenia, pure red cell aplasia and autoimmune neutropenia are less common, while non-hematological autoimmunity is rare. The UK CLL4 trial is the largest prospective trial in CLL to examine the significance of both a positive direct antiglobulin test (DAT) and AHA. The study confirmed the usefulness of the DAT in predicting the development of AHA or not, demonstrated that AHA occurred more frequently in patients receiving treatment with chlorambucil or fludarabine alone compared with the combination of fludarabine and cyclophosphamide, and showed that a positive DAT and the development of AHA were poor prognostic markers. Management of CLL-associated autoimmunity rests on good supportive care and the use of immunosuppressive therapies such as steroids and cyclosporine. Splenectomy remains useful, and monoclonal antibodies (rituximab and alemtuzumab) have given promising results.Keywords
This publication has 37 references indexed in Scilit:
- Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesisBlood, 2008
- From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunityAutoimmunity Reviews, 2007
- Tumor-derived IL-6 may contribute to the immunological defect in CLLLeukemia, 2007
- Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cellsJCI Insight, 2005
- HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemiaBlood, 2005
- Similar Humoral Immunity Parameters in Chronic Lymphocytic Leukemia Patients Independent of VH Gene Mutation StatusLeukemia & Lymphoma, 2004
- Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemiaBlood, 2003
- Abnormal T-cell Function in B-cell Chronic Lymphocytic LeukaemiaLeukemia & Lymphoma, 2003
- Humoral Immunodeficiency in Chronic Lymphocytic Leukemia: Role of CD95/CD95L in Tumoral Damage and EscapeLeukemia & Lymphoma, 2002
- Serum Immunoglobulins and Lymphocyte Subsets in Chronic Lymphocytic LeukemiaAmerican Journal of Clinical Pathology, 1987